Similar articles

• Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

  Block GA, Port FK. Block GA, et al. Am J Kidney Dis. 2000 Jun;35(6):1226-37. doi: 10.1016/s0272-6386(00)70064-3. Am J Kidney Dis. 2000. PMID: 10845841 Review.
• New developments in hyperphosphatemia management.

  Slatopolsky E. Slatopolsky E. J Am Soc Nephrol. 2003 Sep;14(9 Suppl 4):S297-9. doi: 10.1097/01.asn.0000081668.41546.2b. J Am Soc Nephrol. 2003. PMID: 12939384 Review. No abstract available.
• Metastatic cardiac calcification in a patient with chronic renal failure who was undergoing hemodialysis: radiographic and CT findings.

  Jing J, Kawashima A, Sickler K, Raval BK, Oldham SA. Jing J, et al. AJR Am J Roentgenol. 1998 Apr;170(4):903-5. doi: 10.2214/ajr.170.4.9530031. AJR Am J Roentgenol. 1998. PMID: 9530031 No abstract available.
• Calcium and phosphorus metabolism in maintenance hemodialysis.

  Ritz E, Mehls O, Krempien B. Ritz E, et al. Adv Nephrol Necker Hosp. 1980;9:71-108. Adv Nephrol Necker Hosp. 1980. PMID: 6773320 Review. No abstract available.
• [Posttransplant regression of uremic tumoral calcinosis].

  de Alarcón RM, Palomares M, Marfil A, Asensio C. de Alarcón RM, et al. Nefrologia. 2007;27(3):378-81. Nefrologia. 2007. PMID: 17725459 Spanish.